Van Huis, Chad A <br/><br/>
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.  [electronic resource] 

 -  Chemical biology & drug design  Jun 2007 
 - 444-50 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1747-0277 
<br/><br/><label>Standard No.: </label>10.1111/j.1747-0285.2007.00520.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antithrombin III--chemistry<br/>Chemistry, Pharmaceutical--methods<br/>Crystallization<br/>Dogs<br/>Drug Design<br/>Humans<br/>Inhibitory Concentration 50<br/>Models, Chemical<br/>Models, Molecular<br/>Protein Binding<br/>Pyrrolidonecarboxylic Acid--chemistry<br/>Structure-Activity Relationship<br/>Time Factors